Denosumab
Amgen,daiichi sankyo
['denosumab', 'breast', 'bcsm']
oral abstract session at #asco22 on early #breastcancer: updated data from 18 trial showing survival benefit with the addition of #denosumab to adjuvant endocrine therapy in post-menopausal patients receiving aromatase inhibitors #bcsm 
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Prior @myESMO fellow. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.